Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.
about
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin CancerErlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms.Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.Improved Photodynamic Therapy Efficacy of Protoporphyrin IX-Loaded Polymeric Micelles Using Erlotinib Pretreatment.Isolation and characterization of PDT-resistant cancer cells.Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy.Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral CellsWild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line.Porphyrin photosensitizers in photodynamic therapy and its applications.Clarifying binding difference of ATP and ADP to extracellular signal-regulated kinase 2 by using molecular dynamics simulations.Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma
P2860
Q26777814-9707343B-E7A7-43A0-8B7C-4E0998EBA9ACQ35920966-BC35CD5C-418F-4CBE-8E6E-BBA7059B9AF7Q35955366-3F3CAFAF-654A-4495-8AA9-928451B393A4Q36512623-4597A15B-67A9-45C2-BD67-5BC2DE7B6045Q38748824-1A7B5EA4-5CE3-48C5-8DE8-C4E544343C2BQ38823173-11E63637-AD80-49C0-A3CE-EC297C59AEF2Q38903412-1A321A5A-7779-4B64-816D-AF8466543854Q38909313-80A63C0E-9F05-46A4-9E54-9EC795EFF16AQ41779469-05B77B31-11E8-44EE-8FEC-80D77AFB1DBFQ44744253-AC372FF8-05F9-4D81-A39B-5623124150C9Q47096935-6657E3F8-ED97-4635-BD7D-20ED1EAF9577Q51437778-8C992FC2-105D-4C90-860C-26BD2ACFD652Q58758069-A0191B23-4696-4FC4-B9BA-5FF14CF9E093
P2860
Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Sustained ERK [corrected] inhi ...... th PDT as neoadjuvant therapy.
@en
Sustained ERK [corrected] inhi ...... th PDT as neoadjuvant therapy.
@nl
type
label
Sustained ERK [corrected] inhi ...... th PDT as neoadjuvant therapy.
@en
Sustained ERK [corrected] inhi ...... th PDT as neoadjuvant therapy.
@nl
prefLabel
Sustained ERK [corrected] inhi ...... th PDT as neoadjuvant therapy.
@en
Sustained ERK [corrected] inhi ...... th PDT as neoadjuvant therapy.
@nl
P1476
Sustained ERK [corrected] inhi ...... ith PDT as neoadjuvant therapy
@en
P2093
Kristian Berg
P304
P356
10.1016/J.BBAGEN.2012.11.010
P407
P577
2013-03-01T00:00:00Z